Security key
45845P108
- Security type / class
- Equity / COM
- Total 13F shares
- 24,303,337
- Total 13F value
- $335,549,678
- Share change
- +98,217
- Put/Call ratio
- 30%
- SEC-reported price per share
- $13.81
- Number of holders
- 137
- Value change
- -$206,134
- Number of buys
- 53
- Number of sells
- 72
Open additional details 1 more signal available
Report period
Q2 2022
Institutions
137
Top holders
10
Broader feeds
Ownership snapshot
Top reported holders of ICPT - INTERCEPT PHARMACEUTICALS IN - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
—
Disclosed value leader
—
Comparable rows
0/0
Latest evidence
—
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
13F holder rows
Institutional holders as of Q2 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
137
Shares
24,303,337
Rows available
137
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
142
Q2 2022 holders
137
Holder diff
-5
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 value | Q2 2022 value | Value change | Value Chg % |
|---|